CRM Publications

Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, Seo SSoo, Spee B, van Rooijen N et al..  2012.  Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.Nat Med. 18(4):572-9.

Forbes SJ, Newsome PN.  2012.  New horizons for stem cell therapy in liver disease.J Hepatol. 56(2):496-9.

Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott RL, Clayton E, Andreone P, Bernardi M, Golding M et al..  2010.  Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.Gut. 59(5):645-54.

Stutchfield BM, Rashid S, Forbes SJ, Wigmore SJ.  2010.  Practical barriers to delivering autologous bone marrow stem cell therapy as an adjunct to liver resection.Stem Cells Dev. 19(2):155-62.

Stutchfield BM, Forbes SJ, Wigmore SJ.  2010.  Prospects for stem cell transplantation in the treatment of hepatic disease.Liver Transpl. 16(7):827-36.

Dalgetty D, Medine C.N, Iredale JP, Hay DC.  2009.  Progress and future challenges in stem cell-derived liver technologies.Am J Physiol Gastrointest Liver Physiol. 297(2):G241-8.

Bird TG, Lorenzini S, Forbes SJ.  2008.  Activation of stem cells in hepatic diseases.Cell Tissue Res. 331(1):283-300.

Forbes SJ.  2008.  Stem cell therapy for chronic liver disease--choosing the right tools for the job.Gut. 57(2):153-5.